A functioning regulatory framework helps to equip livestock producers with quality products, supporting them to protect their livelihoods and their vital contributions to continental food security.

The Better Regulation project is set to further improve the regulatory systems in sub-Saharan Africa required to bring new veterinary products into market.

Three years since inception and with over a year left on the project, PREVENT has performed remarkably and is on track to achieving, and in some instances exceeding, its targets.

For the past few years, GALVmed has been working with a wide range of partners to create a suite of digital platforms designed to finally bridge the gaps between the animal health industry and the continent’s small-scale producers.

In 2020, LAPROVET, a Ceva Santé Animale group company, partnered with GALVmed and launched the OneLab initiative, a programme to develop a network of private veterinary laboratories in Senegal to facilitate access to diagnostic tools.

As Africa endeavours to intensify its livestock production to meet food security goals, it is imperative to address these gender disparities to avoid unintended consequences and ensure equitable development.

International Women’s Day is a day to reflect on the gender disparities that hinder women’s opportunities worldwide, while advocating for policies and strategies that pave the path to gender equality.

Working in collaboration with partners, GALVmed has implemented, over the years, impactful programmes across Africa and South Asia. These are some of GALVmed’s achievements from 2014 to 2022.

Livestock is a crucial source of income for small-scale livestock producers. Globally, it is estimated that around 78 per cent of the world’s poorest communities rely on agricultural work to support their livelihoods and households. However, livestock diseases represent $358.4 billion in lost production per year.

In order to understand and quantify the causal effects of ND vaccination on poultry production and livelihoods, since 2020, GALVmed has been working with Tufts University and Oxford Policy Management (OPM) to design and implement a Newcastle Disease Vaccine (NDV) intervention paired with a rigorous evaluation in rural areas of Tanzania.